Fresenius Medical Care Ag Revenue Growth Rates (FMS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Fresenius Medical Care Ag  (NYSE: FMS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

FMS's Revenue Growth by Quarter and Year

Fresenius Medical Care Ag's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FMS Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 5,907.97
3rd Quarter September 5,708.16
2nd Quarter June 5,434.56
1st Quarter March 5,140.71
FY 22,191.40

FMSs Annual Revenue
Fresenius Medical Care Ag's Revenue in the fiscal year 2025 $ 21,982.91 millions
Fresenius Medical Care Ag's Revenue in the fiscal year 2024 $ 21,656.22 millions
Fresenius Medical Care Ag's Revenue in the fiscal year 2023 $ 21,788.05 millions
Fresenius Medical Care Ag's Revenue in the fiscal year 2022 $ 21,725.78 millions
Fresenius Medical Care Ag's Revenue in the fiscal year 2021 $ 19,732.93 millions




FMS Revenue fourth quarter 2024 Y/Y Growth Comment
Fresenius Medical Care Ag achieved in the fourth quarter 2024, above Company average Revenue improvement of 8.77% year on year, to $ 5,907.97 millions.

Looking into fourth quarter 2024 results within Healthcare Facilities industry 30 other companies have achieved higher Revenue growth. While Fresenius Medical Care Ag' s Revenue increase of 8.77% ranks overall at the positon no. 2591 in the fourth quarter 2024.


FMS Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 8.77 % 1.18 % 4.45 % -3.62 %
3rd Quarter September 9.14 % -2.66 % 4.74 % -1.99 %
2nd Quarter June 5.91 % -2.33 % 3.75 % -2.73 %
1st Quarter March 0.24 % 1.6 % -1.06 % 0.6 %
FY   6.07 % -0.57 % 2.97 % -

Financial Statements
Fresenius Medical Care Ag's fourth quarter 2024 Revenue $ 5,907.97 millions FMS's Income Statement
Fresenius Medical Care Ag's fourth quarter 2023 Revenue $ 5,431.59 millions Quarterly FMS's Income Statement


FMS Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December 3.5 % 3.86 % -0.08 % 0.19 %
3rd Quarter September 5.03 % 1.92 % 2.26 % 1.3 %
2nd Quarter June 5.72 % 0.06 % 4.09 % -0.74 %
1st Quarter March -5.36 % -4.46 % -1.79 % -4.33 %
FY (Year on Year)   6.07 % -0.57 % 2.97 % -


Back to FMS Growth rate Comparisons >> Back to FMS Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #405
Overall #2591

Revenue Y/Y Growth Statistics
High Average Low
18.29 % -36.54 % -100 %
(Dec 31 2017)   (Dec 31 2018)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #405
Overall #2591
Revenue Y/Y Growth Statistics
High Average Low
18.29 % -36.54 % -100 %
(Dec 31 2017)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Fresenius Medical Care Ag's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5.99 % -8.75 % -100 %
(Jun 30 2018)  


FMS's IV. Quarter Q/Q Revenue Comment
Fresenius Medical Care Ag achieved in the IV. Quarter 2024 above company average sequential Revenue growth of 3.5%, to $ 5,907.97 millions, from $5,708.16 millions in the third quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Fresenius Medical Care Ag's Revenue growth quarter on quarter, overall rank is 1893.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #367
Overall #1893
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #367
Overall #1893
Revenue Q/Q Growth Statistics
High Average Low
5.99 % -8.75 % -100 %
(Jun 30 2018)  


FMS's IV. Quarter Q/Q Revenue Comment
Fresenius Medical Care Ag achieved in the IV. Quarter 2024 above company average sequential Revenue growth of 3.5%, to $ 5,907.97 millions, from $5,708.16 millions in the third quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Fresenius Medical Care Ag's Revenue growth quarter on quarter, overall rank is 1893.


Fresenius Medical Care Ag's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 21,982.91 $ 21,656.22 $ 21,788.05 $ 21,725.78 $ 19,732.93
Y / Y Revenue Growth (TTM) 1.51 % -0.61 % 0.29 % 10.1 % -1.35 %
Year on Year Revenue Growth Overall Ranking # 2525 # 0 # 2410 # 0 # 0
Seqeuential Revenue Change (TTM) 1.51 % -0.61 % 0.29 % 10.1 % -1.35 %
Seq. Revenue Growth (TTM) Overall Ranking # 2525 # 0 # 551 # 0 # 0


Cumulative Revenue growth Comment
Although Fresenius Medical Care Ag's Annual Revenue growth year on year were below company's average 9.86% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.51% year on year, from -0.61% in Dec 31 2024.

In the Healthcare sector 383 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2525.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 35
Healthcare Sector # 384
Overall # 2525

Revenue TTM Y/Y Growth Statistics
High Average Low
102.35 %
 9.86 %
-44.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 384
S&P 500 # 2525
Cumulative Revenue growth Comment
Although Fresenius Medical Care Ag's Annual Revenue growth year on year were below company's average 9.86% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.51% year on year, from -0.61% in Dec 31 2024.

In the Healthcare sector 383 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2525.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 35
Healthcare Sector # 384
Overall # 2525

Revenue TTM Y/Y Growth Statistics
High Average Low
102.35 %
9.86 %
-44.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 384
S&P 500 # 2525




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FMS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Lemaitre Vascular Inc 15.20%$ 15.197 millions
Envista Holdings Corporation15.01%$ 15.011 millions
Radnet Inc 14.80%$ 14.800 millions
Innovage Holding Corp 14.69%$ 14.693 millions
Kamada Ltd 14.54%$ 14.544 millions
Idexx Laboratories Inc14.40%$ 14.398 millions
Cerus Corporation14.33%$ 14.331 millions
Grail Inc 13.97%$ 13.973 millions
Dr Reddy s Laboratories Limited13.76%$ 13.761 millions
Pacific Biosciences Of California Inc 13.75%$ 13.750 millions
Dexcom Inc 13.19%$ 13.189 millions
Atricure Inc 13.05%$ 13.054 millions
Collegium Pharmaceutical Inc 12.92%$ 12.916 millions
Inspire Medical Systems inc 12.58%$ 12.577 millions
Qhslab Inc 12.43%$ 12.433 millions
Pacs Group Inc 12.43%$ 12.426 millions
U S Physical Therapy Inc12.35%$ 12.347 millions
Elanco Animal Health Incorporated12.16%$ 12.157 millions
Livanova Plc11.62%$ 11.618 millions
Amneal Pharmaceuticals Inc 11.59%$ 11.591 millions
Karyopharm Therapeutics Inc 11.58%$ 11.581 millions
Escalon Medical Corp 11.51%$ 11.515 millions
Stryker Corp11.42%$ 11.420 millions
Warby Parker Inc 11.41%$ 11.409 millions
Sight Sciences Inc 11.38%$ 11.385 millions
Novo Nordisk A11.14%$ 11.144 millions
Pro dex Inc 11.14%$ 11.136 millions
Corcept Therapeutics Inc11.12%$ 11.125 millions
Resmed Inc 11.02%$ 11.022 millions
Agape Atp Corporation10.94%$ 10.939 millions


About Fresenius Medical Care Ag Revenue Growth Rates (FMS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Fresenius Medical Care Ag (CIK 1333141).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-019005
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Fresenius Medical Care Ag’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.